These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9696546)

  • 1. Accelerated dissolution rate analysis (ACDRA) for controlled release drugs. Application to Roxiam.
    Zackrisson G; Ostling G; Skagerberg B; Anfält T
    J Pharm Biomed Anal; 1995 Apr; 13(4-5):377-83. PubMed ID: 9696546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical dissolution tests of oral systems based on statistically designed experiments. II. In vitro optimization of screened variables on ER-coated spheres for the establishment of an in vitro/in vivo correlation.
    Abuzarur-Aloul R; Gjellan K; Sjölund M; Graffner C
    Drug Dev Ind Pharm; 1998 Mar; 24(3):203-12. PubMed ID: 9876576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated dissolution testing for improved quality assurance.
    Quist PO; Ostling G
    J Pharm Biomed Anal; 2002 Jun; 28(6):1081-9. PubMed ID: 12049973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo validation of the release rate and palatability of remoxipride-modified release suspension.
    Sjöqvist R; Graffner C; Ekman I; Sinclair W; Woods JP
    Pharm Res; 1993 Jul; 10(7):1020-6. PubMed ID: 8378244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of accelerated drug release testing methods for a matrix-type intravaginal ring.
    Externbrink A; Eggenreich K; Eder S; Mohr S; Nickisch K; Klein S
    Eur J Pharm Biopharm; 2017 Jan; 110():1-12. PubMed ID: 27793758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients.
    Widerlöv E; Franzén G; Jansson P; Movin G
    Int Clin Psychopharmacol; 1990 Apr; 5(2):125-34. PubMed ID: 1974271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput automated dissolution method applicable for a wide dose range of controlled release pellets.
    Petruševska M; Horvat M; Peternel L; Kristan K
    Drug Dev Ind Pharm; 2016; 42(7):1149-57. PubMed ID: 26552838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical analysis of the release of slowly dissolving drugs from spherical matrix systems.
    Frenning G
    J Control Release; 2004 Feb; 95(1):109-17. PubMed ID: 15013238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the feasibility of temperature-controlled accelerated drug release testing for an intravaginal ring.
    Externbrink A; Clark MR; Friend DR; Klein S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):966-73. PubMed ID: 23791685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):335-44. PubMed ID: 8064557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.
    Tan Y; Si X; Zhong L; Feng X; Yang X; Huang M; Wu C
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1669-77. PubMed ID: 27066697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated dissolution testing for controlled release microspheres using the flow-through dissolution apparatus.
    Collier JW; Thakare M; Garner ST; Israel B; Ahmed H; Granade S; Strong DL; Price JC; Capomacchia AC
    Pharm Dev Technol; 2009; 14(1):9-17. PubMed ID: 18785078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic omeprazole delayed-release capsules: in vitro performance evaluations.
    Moore T; Smith A; Ye W; Toler DY; Westenberger BJ; Lionberger R; Raw A; Yu L; Buhse LF
    Drug Dev Ind Pharm; 2009 Aug; 35(8):917-21. PubMed ID: 19555236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution testing of soft shell capsules-acetaminophen and nifedipine.
    Bottom CB; Clark M; Carstensen JT
    J Pharm Sci; 1997 Sep; 86(9):1057-61. PubMed ID: 9294822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release.
    Andreas CJ; Chen YC; Markopoulos C; Reppas C; Dressman J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):39-50. PubMed ID: 26391972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compounding of slow-release niacinamide capsules: feasibility and characterization.
    Radojkovic B; Milić J; Calija B
    Int J Pharm Compd; 2012; 16(5):434-7. PubMed ID: 23072204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3).
    Bakhteyar H; Cassone C; Kohan HG; Sani SN
    Int J Pharm Compd; 2017; 21(5):418-425. PubMed ID: 29216618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of ambroxol sustained release preparations. Part I: In vitro dissolution studies.
    Alighieri T; Avanessian S; Berlini S; Bianchi SG; Deluigi P; Valducci R; Guelen PJ
    Arzneimittelforschung; 1988 Jan; 38(1):92-4. PubMed ID: 3365281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.